NCT06980493Phase 2/3Active, not recruiting
Efficacy and Safety of Topical Amphotericin B Solution in Treatment of Resistant Tinea Capitis in Children 16 Years Old or Less we Follow up Cases Weekly up to 8 Weeks and Notice Improvement of Itching ,Scaling, and Hair Regrowth Then Fungal Culture Done to See if the Solution Working
Efficacy and Safety of Topical Amphotericin B Solution in Treatment of Resistant Tinea Capitis
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Active, not recruiting
- Declared phase
- Phase 2/3
- Sponsor
- Sohag University
- Participants (registry)
- 30
- Start
- April 2025
- Primary completion
- June 2025
- Study completion
- August 2025
- Last registry update
- May 2025
- Countries
- Egypt
Conditions studied: Tinea Capitis
Interventions: Amphotericine in liposome (Ambisome®)
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.